Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 856.43
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 30-Apr-2025
NAV [Rs.]
: 22.2234
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.1 | 2.53 | 2.59 | -3.95 | 13.95 | 17.79 | - | 11.89 |
| Category Avg | 0.83 | 3.08 | 3.44 | -2.83 | 7.96 | 16.03 | 23.18 | 14.37 |
| Category Best | 10.98 | 13.53 | 21.31 | 17.03 | 39.76 | 36.33 | 40.21 | 452.77 |
| Category Worst | -2.47 | -8.66 | -16.21 | -15.84 | -11.39 | 6.15 | 2.73 | -26.32 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 24.90 | 1229110 | 213.21 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 10.80 | 641337 | 92.49 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.76 | 144733 | 83.58 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.29 | 695417 | 79.56 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.52 | 275356 | 55.84 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 4.49 | 119226 | 38.48 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.32 | 318832 | 37.00 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.64 | 128714 | 31.20 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.45 | 60594 | 29.58 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 3.20 | 446154 | 27.36 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.09 | 171649 | 26.45 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.95 | 284739 | 25.23 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.78 | 158418 | 23.79 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.13 | 5945 | 18.26 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 2.05 | 513399 | 17.54 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.69 | 90718 | 14.44 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.55 | 81769 | 13.27 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.47 | 47983 | 12.58 |
| Equity | Natco Pharma | Pharmaceuticals & Biotechnology | 0.95 | 102026 | 8.14 |
| Equity | Granules India | Pharmaceuticals & Biotechnology | 0.93 | 165203 | 8.03 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 0.05 | 0 | 0.41 |
| Cash & Cash Equivalent | C C I | -/- | 3.50 | 0 | 0.00 |
| Net CA & Others | Net CA & Others | -/- | -0.02 | 0 | -0.11 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
5,61,387.15
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
